Paul J. Martin

58.3k total citations · 10 hit papers
568 papers, 34.2k citations indexed

About

Paul J. Martin is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Paul J. Martin has authored 568 papers receiving a total of 34.2k indexed citations (citations by other indexed papers that have themselves been cited), including 367 papers in Hematology, 204 papers in Immunology and 93 papers in Oncology. Recurrent topics in Paul J. Martin's work include Hematopoietic Stem Cell Transplantation (347 papers), T-cell and B-cell Immunology (136 papers) and Immune Cell Function and Interaction (103 papers). Paul J. Martin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (347 papers), T-cell and B-cell Immunology (136 papers) and Immune Cell Function and Interaction (103 papers). Paul J. Martin collaborates with scholars based in United States, South Africa and Canada. Paul J. Martin's co-authors include John A. Hansen, Mary E.D. Flowers, Rainer Storb, Frederick R. Appelbaum, Barry E. Storer, Claudio Anasetti, Effie W. Petersdorf, Stephanie J. Lee, H. Joachim Deeg and Brenda M. Sandmaier and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Paul J. Martin

554 papers receiving 33.4k citations

Hit Papers

Reduced Mortality after Allog... 1982 2026 1996 2011 2010 2002 2001 1985 1982 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul J. Martin United States 98 20.5k 12.4k 6.9k 4.9k 4.5k 568 34.2k
Daniel J. Weisdorf United States 96 24.2k 1.2× 13.3k 1.1× 11.4k 1.6× 6.3k 1.3× 5.1k 1.1× 732 38.4k
Gèrard Socié France 91 18.7k 0.9× 9.2k 0.7× 7.4k 1.1× 4.9k 1.0× 4.8k 1.1× 701 30.2k
Claudio Anasetti United States 89 20.3k 1.0× 11.9k 1.0× 5.5k 0.8× 4.7k 1.0× 3.6k 0.8× 459 27.7k
Jerome Ritz United States 103 12.9k 0.6× 19.0k 1.5× 10.1k 1.4× 3.1k 0.6× 4.8k 1.1× 610 36.4k
Joseph H. Antin United States 90 17.8k 0.9× 9.5k 0.8× 6.4k 0.9× 4.2k 0.9× 3.8k 0.8× 491 28.0k
David G. Maloney United States 85 11.3k 0.6× 8.0k 0.6× 15.0k 2.2× 3.2k 0.7× 5.1k 1.1× 499 30.0k
Arnon Nagler Israel 88 21.6k 1.1× 12.6k 1.0× 12.5k 1.8× 5.4k 1.1× 6.0k 1.3× 1.1k 39.3k
Brenda M. Sandmaier United States 74 16.1k 0.8× 5.1k 0.4× 5.4k 0.8× 4.8k 1.0× 3.5k 0.8× 421 21.8k
Frederick R. Appelbaum United States 105 30.9k 1.5× 7.0k 0.6× 10.1k 1.5× 10.6k 2.1× 8.9k 2.0× 595 42.6k
Stephen J. Forman United States 100 12.3k 0.6× 9.1k 0.7× 16.3k 2.3× 4.8k 1.0× 4.5k 1.0× 861 36.2k

Countries citing papers authored by Paul J. Martin

Since Specialization
Citations

This map shows the geographic impact of Paul J. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Martin more than expected).

Fields of papers citing papers by Paul J. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Martin. The network helps show where Paul J. Martin may publish in the future.

Co-authorship network of co-authors of Paul J. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Martin. A scholar is included among the top collaborators of Paul J. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Martin. Paul J. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morishita, Takanobu, Paul J. Martin, & Yoshihiro Inamoto. (2025). Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease. Cells. 14(4). 238–238. 1 indexed citations
2.
Baumrin, Emily, Michael Byrne, Paul J. Martin, et al.. (2023). Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. JAMA Dermatology. 159(4). 393–393. 7 indexed citations
3.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2022). Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation. Blood Advances. 6(8). 2608–2617. 5 indexed citations
4.
Nguyen, David‐Dan, Bilal Chughtai, Dean Elterman, et al.. (2021). Evaluating the acceptability of an online patient decision aid for the surgical management of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Canadian Urological Association Journal. 15(8). 247–54. 11 indexed citations
5.
Casto, Amanda M., Sachiko Seo, David Levine, et al.. (2021). Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation. Blood. 138(17). 1628–1636. 5 indexed citations
6.
Byrne, Michael, et al.. (2020). 434 Association of skin response in erythema and sclerosis with survival in chronic graft-versus-host disease. Journal of Investigative Dermatology. 140(7). S57–S57. 2 indexed citations
7.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2020). Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation. Blood Advances. 4(14). 3224–3233. 17 indexed citations
8.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2016). Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease. Blood. 129(6). 791–798. 76 indexed citations
9.
Inamoto, Yoshihiro, Paul J. Martin, Mary E.D. Flowers, et al.. (2016). Genetic risk factors for sclerotic graft-versus-host disease. Blood. 128(11). 1516–1524. 9 indexed citations
10.
Cooke, Kenneth R., Leo Luznik, Stefanie Sarantopoulos, et al.. (2016). The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(2). 211–234. 283 indexed citations breakdown →
11.
Yu, Jeffrey, Barry E. Storer, Kushi Kushekhar, et al.. (2016). Biomarker Panel for Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 34(22). 2583–2590. 89 indexed citations
12.
Hahn, Theresa, Lara E. Sucheston‐Campbell, Leah Preus, et al.. (2015). Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(9). 1679–1686. 16 indexed citations
13.
Inamoto, Yoshihiro, Mary E.D. Flowers, Brenda M. Sandmaier, et al.. (2014). Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. Blood. 124(8). 1363–1371. 86 indexed citations
14.
Flowers, Mary E.D., Yoshihiro Inamoto, Paul A. Carpenter, et al.. (2011). Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 117(11). 3214–3219. 453 indexed citations breakdown →
15.
Eissa, Hesham, Ted Gooley, Mohamed L. Sorror, et al.. (2010). Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities. Biology of Blood and Marrow Transplantation. 17(6). 908–915. 81 indexed citations
16.
Martin, Paul J. & Steven Z. Pavletic. (2008). Biology and Management of Chronic Graft-Versus-Host Disease. Cancer treatment and research. 144. 277–298. 8 indexed citations
17.
Flowers, Mary E.D., Barry E. Storer, Paul A. Carpenter, et al.. (2008). Treatment Change as a Predictor of Outcome among Patients with Classic Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 14(12). 1380–1384. 44 indexed citations
18.
Flowers, Mary E.D., Carlos Roberto de Medeiros, Marco A. Bitencourt, et al.. (2005). Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia. British Journal of Haematology. 130(1). 99–106. 33 indexed citations
19.
Petersdorf, E.W., Claudio Anasetti, Paul J. Martin, & John A. Hansen. (2003). Tissue typing in support of unrelated hematopoietic cell transplantation. Tissue Antigens. 61(1). 1–11. 47 indexed citations
20.
Clark, Joan G., et al.. (2000). Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells.. PubMed. 70(1). 39–43. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026